REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) has been given a consensus rating of “Moderate Buy” by the seven research firms that are covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price objective among […]
Related Keywords
Canada , William Blair , Steve Pakola , Stifel Nicolaus , Headlands Technologies , Securities Exchange Commission , Royal Bank , Financial Services Group Inc , Northwestern Mutual Wealth Management Co , Nasdaq , Regenxbio Inc , Technology Platform , Get Free Report , Exchange Commission , Services Group , Financial Advisors , Mutual Wealth Management , Get Free , Regenxbio , Nasdaq Rgnx , Rgnx , Medical , Ratings , Consensus ,
comparemela.com © 2020. All Rights Reserved.